Table of Content



1. Research Scope & Methodology
1.1. Study Objectives
1.2. Scope Of Study
1.3. Methodology
1.4. Assumptions & Limitations

2. Executive Summary
2.1. Market Size & Estimates
2.2. Market Overview

3. Market Dynamics
3.1. Key Drivers
3.1.1. Increasing Cellular Therapy Clinical Trials
3.1.2. Growth Of Regenerative Medicine
3.1.3. High Prevalence Of Chronic Diseases
3.2. Key Restraints
3.2.1. Increasing Skills Gap
3.2.2. High Costs

4. Key Analytics
4.1. Impact Of Covid-19 On Cell Therapy Market
4.2. Key Market Trends
4.3. Porter’S Five Forces Analysis
4.3.1. Buyers Power
4.3.2. Suppliers Power
4.3.3. Substitution
4.3.4. New Entrants
4.3.5. Industry Rivalry
4.4. Regulatory Framework
4.5. Opportunity Matrix
4.6. Vendor Landscape

5. Market By Cell Type
5.1. Stem Cell
5.1.1. Bone Marrow
5.1.2. Blood
5.1.3. Umbilical Cord-Derived Stem Cell
5.1.4. Adipose-Derived Stem Cell
5.1.5. Others
5.2. Non-Stem Cell

6. Market By Therapy Type
6.1. Autologous
6.2. Allogeneic

7. Market By Therapeutic Application
7.1. Malignancies
7.2. Musculoskeletal Disorders
7.3. Autoimmune Disorders
7.4. Dermatology
7.5. Other Applications

8. Market By End-User
8.1. Hospitals & Clinics
8.2. Academic & Research Institutes

9. Geographical Analysis
9.1. North America
9.1.1. Market Size & Estimates
9.1.2. Key Drivers
9.1.3. Key Challenges
9.1.4. Key Players
9.1.5. Country Analysis
9.1.5.1. United States
9.1.5.2. Canada
9.2. Europe
9.2.1. Market Size & Estimates
9.2.2. Key Drivers
9.2.3. Key Challenges
9.2.4. Key Players
9.2.5. Country Analysis
9.2.5.1. United Kingdom
9.2.5.2. Germany
9.2.5.3. France
9.2.5.4. Italy
9.2.5.5. Spain
9.2.5.6. Belgium
9.2.5.7. Poland
9.2.5.8. Rest Of Europe
9.3. Asia-Pacific
9.3.1. Market Size & Estimates
9.3.2. Key Drivers
9.3.3. Key Challenges
9.3.4. Key Players
9.3.5. Country Analysis
9.3.5.1. China
9.3.5.2. Japan
9.3.5.3. India
9.3.5.4. South Korea
9.3.5.5. Thailand
9.3.5.6. Singapore
9.3.5.7. Australia & New Zealand
9.3.5.8. Rest Of Asia-Pacific
9.4. Rest Of World
9.4.1. Market Size & Estimates
9.4.2. Key Drivers
9.4.3. Key Challenges
9.4.4. Key Players
9.4.5. Regional Analysis
9.4.5.1. Latin America
9.4.5.2. Middle East & Africa

10. Competitive Landscape
10.1. Key Strategic Developments
10.1.1. Mergers & Acquisitions
10.1.2. Product Launches & Developments
10.1.3. Partnerships & Agreements
10.1.4. Business Expansions
10.2. Company Profiles
10.2.1. Anterogen Co Ltd
10.2.2. Bristol Myers Squibb Company
10.2.3. Cells For Cells Sa
10.2.4. Gilead Sciences Inc
10.2.5. Jcr Pharmaceuticals Co Ltd
10.2.6. Kolon Tissuegene Inc
10.2.7. Medipost Co Ltd
10.2.8. Mesoblast Limited
10.2.9. Nuvasive Inc
10.2.10. Smith & Nephew Plc
10.2.11. Stemedica Cell Technologies Inc
10.2.12. Vericel Corporation



List of Figures

List Of Figures
Figure 1: Key Market Trends
Figure 2: Porter’S Five Forces Analysis
Figure 3: Opportunity Matrix
Figure 4: Vendor Landscape
Figure 5: Global Cell Therapy Market, Growth Potential, By Cell Type, In 2021
Figure 6: Global Cell Therapy Market, By Stem Cell, 2022-2030 (In $ Million)
Figure 7: Global Cell Therapy Market, Growth Potential, By Stem Cell, In 2021
Figure 8: Global Cell Therapy Market, By Bone Marrow, 2022-2030 (In $ Million)
Figure 9: Global Cell Therapy Market, By Blood, 2022-2030 (In $ Million)
Figure 10: Global Cell Therapy Market, By Umbilical Cord-Derived Stem Cell, 2022-2030 (In $ Million)
Figure 11: Global Cell Therapy Market, By Adipose-Derived Stem Cell, 2022-2030 (In $ Million)
Figure 12: Global Cell Therapy Market, By Others, 2022-2030 (In $ Million)
Figure 13: Global Cell Therapy Market, By Non-Stem Cell, 2022-2030 (In $ Million)
Figure 14: Global Cell Therapy Market, Growth Potential, By Therapy Type, In 2021
Figure 15: Global Cell Therapy Market, By Autologous, 2022-2030 (In $ Million)
Figure 16: Global Cell Therapy Market, By Allogeneic, 2022-2030 (In $ Million)
Figure 17: Global Cell Therapy Market, Growth Potential, By Therapeutic Application, In 2021
Figure 18: Global Cell Therapy Market, By Malignancies, 2022-2030 (In $ Million)
Figure 19: Global Cell Therapy Market, By Musculoskeletal Disorders, 2022-2030 (In $ Million)
Figure 20: Global Cell Therapy Market, By Autoimmune Disorders, 2022-2030 (In $ Million)
Figure 21: Global Cell Therapy Market, By Dermatology, 2022-2030 (In $ Million)
Figure 22: Global Cell Therapy Market, By Other Applications, 2022-2030 (In $ Million)
Figure 23: Global Cell Therapy Market, Growth Potential, By End-User, In 2021
Figure 24: Global Cell Therapy Market, By Hospitals & Clinics, 2022-2030 (In $ Million)
Figure 25: Global Cell Therapy Market, By Academic & Research Institutes, 2022-2030 (In $ Million)
Figure 26: North America Cell Therapy Market, Country Outlook, 2021 & 2030 (In %)
Figure 27: United States Cell Therapy Market, 2022-2030 (In $ Million)
Figure 28: Canada Cell Therapy Market, 2022-2030 (In $ Million)
Figure 29: Europe Cell Therapy Market, Country Outlook, 2021 & 2030 (In %)
Figure 30: United Kingdom Cell Therapy Market, 2022-2030 (In $ Million)
Figure 31: Germany Cell Therapy Market, 2022-2030 (In $ Million)
Figure 32: France Cell Therapy Market, 2022-2030 (In $ Million)
Figure 33: Italy Cell Therapy Market, 2022-2030 (In $ Million)
Figure 34: Spain Cell Therapy Market, 2022-2030 (In $ Million)
Figure 35: Belgium Cell Therapy Market, 2022-2030 (In $ Million)
Figure 36: Poland Cell Therapy Market, 2022-2030 (In $ Million)
Figure 37: Rest Of Europe Cell Therapy Market, 2022-2030 (In $ Million)
Figure 38: Asia-Pacific Cell Therapy Market, Country Outlook, 2021 & 2030 (In %)
Figure 39: China Cell Therapy Market, 2022-2030 (In $ Million)
Figure 40: Japan Cell Therapy Market, 2022-2030 (In $ Million)
Figure 41: India Cell Therapy Market, 2022-2030 (In $ Million)
Figure 42: South Korea Cell Therapy Market, 2022-2030 (In $ Million)
Figure 43: Thailand Cell Therapy Market, 2022-2030 (In $ Million)
Figure 44: Singapore Cell Therapy Market, 2022-2030 (In $ Million)
Figure 45: Australia & New Zealand Cell Therapy Market, 2022-2030 (In $ Million)
Figure 46: Rest Of Asia-Pacific Cell Therapy Market, 2022-2030 (In $ Million)
Figure 47: Rest Of World Cell Therapy Market, Regional Outlook, 2021 & 2030 (In %)
Figure 48: Latin America Cell Therapy Market, 2022-2030 (In $ Million)
Figure 49: Middle East & Africa Cell Therapy Market, 2022-2030 (In $ Million

List of Tables

LIST OF TABLES
TABLE 1: MARKET SNAPSHOT – CELL THERAPY
TABLE 2: REGULATORY FRAMEWORK
TABLE 3: GLOBAL CELL THERAPY MARKET, BY CELL TYPE, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 4: GLOBAL CELL THERAPY MARKET, BY CELL TYPE, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 5: GLOBAL STEM CELL MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 6: GLOBAL STEM CELL MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 7: GLOBAL CELL THERAPY MARKET, BY STEM CELL, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 8: GLOBAL CELL THERAPY MARKET, BY STEM CELL, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 9: GLOBAL BONE MARROW MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 10: GLOBAL BONE MARROW MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 11: GLOBAL BLOOD MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 12: GLOBAL BLOOD MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 13: GLOBAL UMBILICAL CORD-DERIVED STEM CELL MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 14: GLOBAL UMBILICAL CORD-DERIVED STEM CELL MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 15: GLOBAL ADIPOSE-DERIVED STEM CELL MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 16: GLOBAL ADIPOSE-DERIVED STEM CELL MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 17: GLOBAL OTHERS MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 18: GLOBAL OTHERS MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 19: GLOBAL NON-STEM CELL MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 20: GLOBAL NON-STEM CELL MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 21: GLOBAL CELL THERAPY MARKET, BY THERAPY TYPE, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 22: GLOBAL CELL THERAPY MARKET, BY THERAPY TYPE, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 23: GLOBAL AUTOLOGOUS MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 24: GLOBAL AUTOLOGOUS MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 25: GLOBAL ALLOGENEIC MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 26: GLOBAL ALLOGENEIC MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 27: GLOBAL CELL THERAPY MARKET, BY THERAPEUTIC APPLICATION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 28: GLOBAL CELL THERAPY MARKET, BY THERAPEUTIC APPLICATION, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 29: GLOBAL MALIGNANCIES MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 30: GLOBAL MALIGNANCIES MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 31: GLOBAL MUSCULOSKELETAL DISORDERS MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 32: GLOBAL MUSCULOSKELETAL DISORDERS MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 33: GLOBAL AUTOIMMUNE DISORDERS MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 34: GLOBAL AUTOIMMUNE DISORDERS MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 35: GLOBAL DERMATOLOGY MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 36: GLOBAL DERMATOLOGY MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 37: GLOBAL OTHER APPLICATIONS MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 38: GLOBAL OTHER APPLICATIONS MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 39: GLOBAL CELL THERAPY MARKET, BY END-USER, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 40: GLOBAL CELL THERAPY MARKET, BY END-USER, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 41: GLOBAL HOSPITALS & CLINICS MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 42: GLOBAL HOSPITALS & CLINICS MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 43: GLOBAL ACADEMIC & RESEARCH INSTITUTES MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 44: GLOBAL ACADEMIC & RESEARCH INSTITUTES MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 45: GLOBAL CELL THERAPY MARKET, BY GEOGRAPHY, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 46: GLOBAL CELL THERAPY MARKET, BY GEOGRAPHY, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 47: NORTH AMERICA CELL THERAPY MARKET, BY COUNTRY, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 48: NORTH AMERICA CELL THERAPY MARKET, BY COUNTRY, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 49: KEY PLAYERS IN NORTH AMERICA CELL THERAPY MARKET
TABLE 50: LIST FDA-APPROVED CELL THERAPY PRODUCTS
TABLE 51: EUROPE CELL THERAPY MARKET, BY COUNTRY, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 52: EUROPE CELL THERAPY MARKET, BY COUNTRY, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 53: KEY PLAYERS IN EUROPE CELL THERAPY MARKET
TABLE 54: ASIA-PACIFIC CELL THERAPY MARKET, BY COUNTRY, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 55: ASIA-PACIFIC CELL THERAPY MARKET, BY COUNTRY, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 56: KEY PLAYERS IN ASIA-PACIFIC CELL THERAPY MARKET
TABLE 57: REST OF WORLD CELL THERAPY MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 58: REST OF WORLD CELL THERAPY MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 59: KEY PLAYERS IN REST OF WORLD CELL THERAPY MARKET
TABLE 60: LIST OF MERGERS & ACQUISITIONS
TABLE 61: LIST OF PRODUCT LAUNCHES & DEVELOPMENTS
TABLE 62: LIST OF PARTNERSHIPS & AGREEMENTS
TABLE 63: LIST OF BUSINESS EXPANSIONS